BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33331925)

  • 1. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
    Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
    Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
    Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
    Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma.
    Oishi N; Hundal T; Phillips JL; Dasari S; Hu G; Viswanatha DS; He R; Mai M; Jacobs HK; Ahmed NH; Syrbu SI; Salama Y; Chapman JR; Vega F; Sidhu J; Bennani NN; Epstein AL; Medeiros JL; Clemens MW; Miranda RN; Feldman AL
    Haematologica; 2021 Jun; 106(6):1714-1724. PubMed ID: 32414854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
    Rondón-Lagos M; Rangel N; Camargo-Villalba G; Forero-Castro M
    Eur J Surg Oncol; 2021 May; 47(5):942-951. PubMed ID: 33158639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
    Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
    Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
    Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
    Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
    Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Blombery P; Thompson ER; Prince HM
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Collins MS; Miranda RN; Medeiros LJ; Silva de Meneses MP; Iyer SP; Butler CE; Liu J; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. PubMed ID: 30817555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
    Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
    Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
    Turner SD; Inghirami G; Miranda RN; Kadin ME
    Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Why Must We Learn About It?
    de Oliveira Sermoud LMC; Romano S; Chveid M; da Silva Amorim GL
    J Glob Oncol; 2019 Aug; 5():1-5. PubMed ID: 31454283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
    Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
    JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.